These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Author: Rhedda A, McCans J, Willan AR, Ford PM.
    Journal: J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157.
    Abstract:
    We report the results of a double blind placebo controlled crossover randomized study of the calcium channel blocking agent diltiazem in the treatment of Raynaud's phenomenon. Our results showed a significant reduction in both frequency and duration of attacks of vasospasm in the hands. There was no detectable difference in response between patients with primary and those with secondary Raynaud's phenomenon. Our study supports the use of calcium channel blocking agents in the treatment of intermittent digital vasospasm.
    [Abstract] [Full Text] [Related] [New Search]